Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Mid-range Performer
5552.5000
-40.00
(
-0.72
%)
NSE
Jan 05, 2026
15:31 PM
Volume:
42,046
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
12 Aug 2025
5552.50
-0.72%
Alkem to accelerate its non-US business as part of long-term growth plans: CEO
Business Line
Plans to set up a subsidiary in Saudi Arabia
Alkem Laboratories Ltd. is trading
above its 200 day SMA
of 5245.6
Alkem Labs Q1 profit rises 22% to 664 cr on India, overseas sales growth
Business Standard |
12 Aug 2025
More from Alkem Laboratories Ltd.
Recommended
IPO activity picks up as Bharat Coking Coal and Six SMEs open for subscription
|
05 Jan 2026, 05:32PM
Market closes lower, amid rising geopolitical uncertainty due to US military action in Venezuela
Trendlyne Marketwatch |
05 Jan 2026, 04:02PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021